The First Chemically-Synthesised, Highly Immunogenic Anti-SARS-CoV-2 Peptides in DNA Genotyped Aotus Monkeys for Human Use

Thirty-five peptides selected from functionally-relevant SARS-CoV-2 spike (S), membrane (M), and envelope (E) proteins were suitably modified for immunising MHC class II (MHCII) DNA-genotyped Aotus monkeys and matched with HLA-DRβ1* molecules for use in humans. This was aimed at producing the first...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Manuel E. Patarroyo, Manuel A. Patarroyo, Martha P. Alba, Laura Pabon, María T. Rugeles, Wbeimar Aguilar-Jimenez, Lizdany Florez, Adriana Bermudez, Ashok K. Rout, Christian Griesinger, Carlos F. Suarez, Jorge Aza-Conde, César Reyes, Catalina Avendaño, Jhoan Samacá, Anny Camargo, Yolanda Silva, Martha Forero, Edgardo Gonzalez
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2021-09-01
Saila:	Frontiers in Immunology
Gaiak:	SARS-CoV-2 neutralising antibody MHCII-peptide-TCR complex modified synthetic peptide HLA-DRβ1*/Aona-DRβ PPIIL-propensity
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.724060/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!